首页> 外文期刊>European journal of endocrinology >Natural history of autoimmune primary ovarian insufficiency in patients with Addison’s disease: from normal ovarian function to overt ovarian dysfunction
【24h】

Natural history of autoimmune primary ovarian insufficiency in patients with Addison’s disease: from normal ovarian function to overt ovarian dysfunction

机译:艾迪生病患者自身免疫性原发性卵巢功能不全的自然病史:从正常的卵巢功能到明显的卵巢功能障碍

获取原文
           

摘要

Context Women with autoimmune Addison’s disease with normal ovulatory cycles but positive for steroid cell antibodies (StCA) have been considered at risk of premature ovarian insufficiency (POI). Design Thirty-three women younger than 40 years, with subclinical-clinical autoimmune Addison’s disease but with normally ovulatory menses, were followed up for 10 years to evaluate the long-term time-related variations of StCA, ovarian function and follicular reserve. All patients and 27 control women were investigated at the start and every year for the presence and titre of StCA (by indirect immunofluorescence), serum concentrations of anti-Mullerian hormone (AMH) and ovarian function at four consecutive menses every year. Results At the start of the study StCA were present in 16 women (group 1), at low/middle titres (≤1:32) in seven of them (43.8%, group 1A), at high titres (>1:32) in the remaining nine patients (group 1B, 56.2%), while they were absent from 17 patients (group 2). During the follow-up period, all women in group 1A remained StCA-positive at low/middle titres with normal ovulatory menses and normal gonadotrophin and AMH levels, while all patients in group 1B showed a further increase of StCA titres (1:128–1:256) and progressed through three stages of ovarian function. None of the patients in group 2 and controls showed the appearance of StCA or ovarian dysfunction during the follow-up. Conclusions The presence of StCA at high titres can be considered a good predictive marker of subsequent development of autoimmune POI. To single out the stages of autoimmune POI may allow a timely therapeutic choice in the subclinical and early clinical stages.
机译:背景技术具有正常排卵周期,但类固醇细胞抗体(StCA)阳性的自身免疫性艾迪生氏病的女性被认为有卵巢早衰(POI)的风险。设计对33名年龄在40岁以下,患有亚临床自身免疫性艾迪生氏病但排卵期正常的女性进行了随访10年,以评估StCA,卵巢功能和卵泡储备的长期长期变化。所有患者和27名对照女性在开始时和每年都要进行一次StCA(间接免疫荧光)检测及其滴度,抗-Mullerian激素(AMH)的血清浓度和每年四个连续月经的卵巢功能的检查。结果在研究开始时,有16名女性(第1组)中存在StCA,其中低/中效价(≤1:32)中有7名女性(43.8%,1A组)中具有高滴度(> 1:32)。其余9例患者(1B组,占56.2%),而17例患者(2组)中则没有。在随访期间,第1A组的所有妇女在低/中滴度,排卵期正常,促性腺激素和AMH水平正常的情况下,StCA阳性,而第1B组的所有患者的StCA滴度进一步升高(1:128 1:256),并经历了卵巢功能的三个阶段。在随访期间,第2组和对照组的患者均未显示出StCA或卵巢功能障碍。结论高滴度存在StCA可被认为是自身免疫性POI后续发展的良好预测指标。选出自身免疫性POI的阶段可以在亚临床阶段和早期临床阶段中进行及时的治疗选择。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号